超乳玻切一体机
Search documents
各地企业开工忙 冲刺“开门红”
Jing Ji Wang· 2026-02-26 02:40
春节假期后首个工作日,各地企业锚定年度目标,抢时间、拼效率、提产能,全国各地企业迎来开工热 潮。专家表示,此次春节后复工复产热潮,不仅彰显了我国企业的强劲韧性与发展活力,也为 2026 年经 济高质量发展奠定了坚实基础。 本报记者 王琰 2月24日,春节假期后首个工作日,全国各地企业迎来开工热潮。各地企业锚定年度目标,抢时间、拼 效率、提产能,以开局即冲刺、起步即决战的奋进姿态,全力冲刺一季度"开门红"。 重大项目集中开工 项目建设是经济增长的"压舱石"。马年新春,江苏各地重大项目全线发力,从南到北皆是热火朝天的建 设场景。 24日早8点,苏州市相城区苏州北站综合枢纽项目已是一片繁忙景象:地面上塔吊林立,钢索紧绷运送 建材;地下20多米深的基坑内,工人俯身加固螺栓,敲击声此起彼伏,施工节奏分秒不停。苏州高铁枢 纽投资开发有限公司副总经理魏荣亮表示,该项目计划2027年底完工,建成后将推动苏州跻身长三 角"十"字发展轴枢纽中心,全面提升城市能级与核心竞争力。 无独有偶,24日清晨,常州高新区罗森伯格常州智慧工厂建设现场,施工人员与企业监理人员已悉数到 岗。这个总投资超1亿美元的重点项目,春节前已完成主体结构封顶 ...
春节后开工一线观察:策马扬鞭再出发
Xin Lang Cai Jing· 2026-02-25 18:56
落实中央决策部署,各地谋新招出实策—— (来源:工人日报) 2月24日,正月初八,开工! 春节假期后,多地吹响奋进号角,重大项目开工蹄疾步稳,企业生产线开足马力赶订单、保供应,"十 五五"开局之年,奋力跑出万马奔腾的昂扬气势。 凝心聚力,绘就全年"施工图" 正月初八,岭南春早。2026年广东省高质量发展大会如约而至,这是广东连续四年在春节后首个工作日 举办高质量发展大会。 从明确"再造一个新广东"的目标,到创新驱动、现代化产业体系建设,再到今年"制造业与服务业协同 发展",广东"新春第一会"的主题年年深入,一以贯之推动高质量发展。 春节假期节后首日,多地"新春第一会"召开,以"开局即冲刺"的姿态绘就全年"施工图",为高质量发展 部署"任务书"。 江淮腹地,合肥"新春第一会"聚焦"科技创新引领新质生产力发展"。科研人员、企业家、基层干部齐聚 一堂,共商创新之策。"'新春第一会'再次强调科技创新,让我们充满信心,新的一年企业将坚持以实 干争先,以创新赋能。"蔚来汽车创始人李斌说。 三湘大地,湖南省召开全省促进民营经济发展壮大暨企业服务年行动部署大会。今年湖南提出实施"企 业服务年"行动,将政府服务的触角延伸到每一 ...
策马扬鞭再出发
Xin Lang Cai Jing· 2026-02-24 19:18
转自:贵州日报 2月24日,在山东省烟台市芝罘区只楚街道一家制冷设备和换热装置制造企业,工人在生产线上忙碌。 新华/传真 2月24日,正月初八,开工! 春节假期后首个工作日,多地以"新春第一会"吹响奋进号角,重大项目开工蹄疾步稳,企业生产线开足 马力赶订单、保供应,"十五五"开局之年,奋力跑出万马奔腾的昂扬气势。 凝心聚力,绘就全年"施工图" 正月初八,岭南春早。2026年广东省高质量发展大会如约而至,这是广东连续四年在春节后首个工作日 举办高质量发展大会。 从明确"再造一个新广东"的目标,到创新驱动、现代化产业体系建设,再到今年"制造业与服务业协同 发展",广东"新春第一会"的主题年年深入,一以贯之推动高质量发展。 春节假期节后首日,多地"新春第一会"召开,以"开局即冲刺"的姿态绘就全年"施工图",为高质量发展 部署"任务书"。 江淮腹地,合肥"新春第一会"聚焦"科技创新引领新质生产力发展"。科研人员、企业家、基层干部齐聚 一堂,共商创新之策。"'新春第一会'再次强调科技创新,让我们充满信心,新的一年企业将坚持以实 干争先,以创新赋能。"蔚来汽车创始人李斌说。 三湘大地,湖南省召开全省促进民营经济发展壮大暨 ...
频现亿元级融资,这一眼科重磅设备已到国产爆发前夜
3 6 Ke· 2025-10-21 03:24
Core Insights - The Chinese medical device market, particularly in ophthalmology, has long been dominated by international giants, with Alcon holding nearly half of the market share [1][2] - Recent developments indicate a surge in domestic companies focusing on the development of phacoemulsification and vitrectomy integrated machines, despite the absence of approved domestic products [2][3] - The integrated phaco-vitrectomy machine is crucial as it addresses the increasing complexity of eye surgeries, allowing simultaneous treatment of cataracts and vitreous diseases [4][5] Industry Developments - Domestic companies have recently secured significant funding for the development of phaco-vitrectomy machines, indicating a shift in the market landscape [2][3] - The emergence of multiple financing events within a short period highlights a collective effort among domestic firms to enter this high-tech segment [2][3] - The integrated machine is seen as a solution to improve surgical efficiency and patient outcomes by reducing the need for multiple devices during surgery [5][6] Technical Challenges - The development of the phaco-vitrectomy machine is technically complex, particularly the vitrectomy component, which requires advanced control systems and stability [6][7] - Companies must integrate various technologies, including fluid control and energy systems, to ensure the machine's reliability and performance [6][7] - The regulatory environment poses additional challenges, as these devices are classified as Class III medical devices, requiring lengthy approval processes [7] Market Dynamics - The market for phaco-vitrectomy machines is poised for growth due to increasing demand from secondary and tertiary hospitals for updated equipment [8] - The domestic market is experiencing a "critical point" where technological advancements and policy support are aligning to favor local manufacturers [8][11] - The competition is not just about product features but also about the overall system performance and user experience in clinical settings [22][23] Future Outlook - The next few years are expected to see a concentration of product approvals, with several companies nearing the completion of their development processes [10][21] - The transition from having products to achieving market penetration will be gradual, influenced by clinical acceptance and policy support for domestic products [11][23] - The long-term trend indicates a clear shift towards domestic alternatives in the ophthalmic device market, driven by both technological advancements and regulatory changes favoring local production [11][12]
中国公司全球化周报|中国电信与阿里巴巴合作,服务中国企业出海/霸王茶姬正式进入菲律宾市场
3 6 Ke· 2025-09-07 01:14
Company Developments - China Telecom and Alibaba have reached a strategic cooperation agreement to jointly serve Chinese enterprises going global, focusing on cloud and AI infrastructure, e-commerce services, and social value innovation [2] - Bawang Tea has officially entered the Philippine market with three stores opening in the Manila metropolitan area, selling over 23,000 cups in the first three days, marking its seventh international market [2] - KUKA Home plans to invest approximately 1.12 billion yuan to build a self-owned base in Indonesia, expecting an annual revenue of about 2.52 billion yuan upon completion [3] - Stone Technology has achieved the number one global market share in both cleaning robots and vacuum robots for the first half of 2025, with shares of 15.2% and 20.7% respectively [3] - Alibaba's AliExpress is preparing a high-profile brand export project, inviting top global brands to participate, with aggressive growth targets set [3] - Gaode Map has launched ride-hailing services in Canada, New Zealand, Switzerland, and the UAE, expanding its international presence [4] - Xiaomi aims to make 2025 the year for the international expansion of its home appliances and new retail, with plans for automotive exports by 2027 [4] - JD Industrial has signed agreements with two Brazilian companies to enhance the digital supply chain services in the region [5] - BYD has reported that seven out of eight roll-on/roll-off ships are now operational, with significant sales in multiple countries [5] - Proton, supported by Geely, has launched its first electric vehicle factory in Malaysia, with an investment of approximately 138 million yuan [5] Investment and Financing - UBTECH has secured a strategic financing credit line of $1 billion to establish a super factory in the Middle East [6] - Laimu Technology has completed several rounds of financing exceeding 100 million yuan, focusing on the European and American markets for smart lawn mowers [6] - Ruijian Pharmaceutical has raised over 300 million yuan in B-round financing, with plans to accelerate clinical development of Parkinson's treatment products [7] - Ronovo Surgical has completed a D-round financing of $67 million, aiming to expand its modular surgical robot platform globally [7] - Sierra Medical has raised over 100 million yuan to accelerate the development of its ophthalmic products and expand its market presence [8]
眼科创新力量代表再获超亿元融资,加速国产高端眼科器械进口替代进程
Sou Hu Cai Jing· 2025-09-04 13:41
Company Overview - SierraMedical, an innovative domestic ophthalmic medical device company, recently completed a new financing round exceeding 100 million yuan, led by Qianji Capital and Shunwei Capital, with existing shareholders Bohang Capital and Honghui Fund increasing their stakes [1] - Founded in July 2022, SierraMedical integrates research and development, production, and sales, focusing on providing precise and intelligent minimally invasive surgical solutions for ophthalmology [3] Product Development - The financing will primarily support the deep development of the company's first self-developed phacoemulsification and vitrectomy integrated machine product line, while also enriching the company's ophthalmic surgical equipment product matrix [1] - SierraMedical has launched the NEXVIT® series of ultra-high-speed dual-blade dual-gas path vitreous cutting heads, achieving a cutting speed of up to 20,000 cuts per minute, which has been clinically validated for performance and safety [3] - The company is also developing a disposable ophthalmic puncture device that features a slanted front cut and a chamfered design to assist surgeons in making precise and safe incisions, minimizing damage to surrounding eye tissue [4] Market Potential - The ophthalmic medical device market in China reached a scale of 45 billion yuan in 2023, with a compound annual growth rate exceeding 15%, significantly higher than the global average [3] - SierraMedical aims to break the monopoly of foreign companies in the high-end ophthalmic surgical instrument sector and address critical instrument supply issues [3] Investment Insight - Qianji Capital and Shunwei Capital, both leading investors in this financing round, have a strong track record in the medical field, with Qianji Capital being one of the earliest specialized funds in healthcare and life sciences in China [6]
8点1氪:宇树科技将在四季度提交IPO申请;雀巢CEO因与下属恋爱被解雇;微信客服回应“去世后朋友圈是否会消失”
36氪· 2025-09-03 00:11
Group 1 - Yushu Technology plans to submit an IPO application to the Chinese Securities Exchange between October and December 2024 [4] - The company's sales for 2024 are expected to be driven by quadruped robots and humanoid robots, accounting for 65% and 30% of total sales respectively [4] Group 2 - Nestlé's CEO Laurent Freixe was dismissed due to an investigation into an undisclosed romantic relationship with a subordinate, violating the company's code of conduct [5] - Philipp Navratil has been appointed as the new CEO of Nestlé, effective immediately [5] - Under Freixe's leadership, Nestlé completed the acquisition of the remaining 40% stake in Xu Fu Ji, marking the end of a 14-year capital journey [5] Group 3 - The acquisition case of Liangpinpuzi by Wuhan Changjiang International Trade Group has entered the acceptance stage as of August 28, 2025 [11] - After the acquisition, Wuhan Changjiang will hold 29.99% of Liangpinpuzi's shares, while Ningbo Hanyi will retain 35.23% [12] Group 4 - Bawang Tea Ji has officially entered the Philippine market with three stores opening in key commercial areas of Metro Manila [13] - The stores sold over 23,000 cups within the first three days of operation [13] Group 5 - The fast delivery industry is experiencing a price increase in core regions, driven by a national "anti-involution" policy [16] - This price adjustment is expected to improve profit margins for delivery companies and enhance the income stability of delivery personnel [16] Group 6 - The current spot gold price has surpassed $3,500 per ounce, marking a historical high with a year-to-date increase of over 33% [16] Group 7 - Tesla has officially launched the nationwide first batch of deliveries for the Model Y L [20]
8点1氪丨宇树科技将在四季度提交IPO申请;雀巢CEO因与下属恋爱被解雇;微信客服回应“去世后朋友圈是否会消失”
3 6 Ke· 2025-09-03 00:10
Group 1 - Good Products' acquisition case has entered the acceptance stage, with Wuhan Yangtze International Trade Group acquiring 29.99% of Good Products' shares [6][7] - Bawang Tea has officially entered the Philippine market, opening three stores in key business districts and selling over 23,000 cups in the first three days [8] - Nestlé's CEO was dismissed due to a romantic relationship with a subordinate, which violated the company's code of conduct [3] Group 2 - Yushun Technology plans to submit an IPO application to the Chinese stock exchange between October and December 2025, with quadruped and humanoid robots expected to account for 65% and 30% of sales in 2024, respectively [2] - Tencent responded to a lawsuit from miHoYo, stating it will comply with legal regulations regarding user data requests [6] - The fast delivery industry is experiencing a price increase in core areas, driven by a national "anti-involution" policy aimed at improving profitability [11] Group 3 - The current spot gold price has surpassed $3,500 per ounce, marking a historical high with a year-to-date increase of over 33% [11] - The U.S. stock market saw all three major indices decline, while many Chinese concept stocks experienced gains [12] - Google was ruled not to divest its Chrome and Android systems in an antitrust case, but must share data with competitors [13] Group 4 - The Chinese Ministry of Foreign Affairs announced a visa-free policy for Russian passport holders from September 15, 2025, to September 14, 2026 [5] - WeChat's customer service clarified that inactive accounts may be reclaimed by the system after one year of inactivity, leading to the loss of all associated data [4] - The company "Sina" announced the resignation of its CEO due to an investigation into the purchase of illegal health products [16] Group 5 - Companies such as Jiadou Technology and XGIMI Technology are planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance competitiveness and international presence [17][19] - "Si Ai Ran Medical" completed a financing round exceeding 100 million yuan to advance its ophthalmic medical device product line [22] - "Lai Mu Technology" secured several million yuan in Series A financing to enhance its smart lawnmower product development and market expansion [24]
氪星晚报 |霸王茶姬正式进入菲律宾市场;宇树科技宣布将在四季度提交IPO申请;金价迭创新高,多家黄金企业半年净利润翻倍
3 6 Ke· 2025-09-02 13:13
Group 1: Financing Activities - Yingfan Technology completed a strategic A-round financing of over 100 million yuan, with funds primarily aimed at enhancing investments in artificial intelligence applications [1] - Wei Yi Culture announced the completion of a million-level angel round financing, with funds allocated for immersive panoramic project development and self-owned IP operations [8] - Si Ai Ran Medical completed a new round of financing exceeding 100 million yuan, with funds focused on the deep development of its first self-developed phacoemulsification and vitrectomy integrated machine product line [9] - Blue Engine, a precision agriculture robotics company, announced the completion of an angel round financing, with funds intended for product R&D upgrades, mass production, and market expansion [10] Group 2: Financial Performance - Xian Dao Intelligent reported a net profit of 375 million yuan for Q2 2025, a year-on-year increase of 456.29%, with total revenue for the first half of 2025 reaching 6.61 billion yuan, up 14.92% year-on-year [2] - NIO achieved revenue of 19.01 billion yuan in Q2 2025, a year-on-year increase of 9.0%, with a gross margin of 10.0% and cash reserves of 27.2 billion yuan [3] Group 3: Market Developments - Yushu Technology plans to submit an IPO application to the Chinese stock exchange between October and December 2025, with quadruped and humanoid robots expected to account for 65% and 30% of 2024 sales, respectively [4] - Wanjing Technology announced the integration of AI-generated content identification technology into multiple products, covering various formats such as JPG, MP4, and PDF [5] - ChatGPT's user base in South Korea surpassed 20 million in August 2023, representing approximately 40% of the country's smartphone users [6] Group 4: Corporate Changes - Audi appointed Guo Yongfeng as the executive vice president of its sales company in China, effective September 1, 2025 [7]
思埃然完成超亿元融资,千骥资本、顺为资本联合领投
Sou Hu Cai Jing· 2025-09-02 08:20
Core Insights - Honghui Fund's portfolio company, Siairan, has completed over 100 million yuan financing, led by Qianji Capital and Shunwei Capital, with existing investors including Boxin Capital and Honghui Fund increasing their stakes [1] - The funds will primarily be used for the in-depth research and development of the company's first self-developed phacoemulsification and vitrectomy integrated machine, as well as to expand the product matrix of ophthalmic surgical equipment [1] - Siairan Medical, established in July 2022, has a core team with extensive industry experience and complete capabilities in R&D, production, and commercialization [1] Company Overview - Siairan Medical focuses on providing precise and intelligent minimally invasive surgical solutions for ophthalmology, aiming to break the monopoly of foreign companies in the high-end ophthalmic surgical instrument sector [1] - The company is addressing critical issues related to key surgical instruments and is currently developing products including the phacoemulsification and vitrectomy integrated machine and digital surgical microscopes [1] - Siairan Medical is committed to offering innovative and high-quality products and services to ophthalmologists and patients, promoting the advancement of ophthalmic medical technology [1]